The delay in Sun Pharma's launch of Leqselvi in the US was caused by a patent infringement case, which was later settled in a ...

LEQSELVI has shown rapid results in clinical trials, with one-third of patients regaining nearly full scalp hair by Week 24.

Shares of Sun Pharma rose 2 percent to Rs 1,711 in morning trade on July 15, extending their gains for a third straight ...

A genetic component is likely, but the traditional use of hot combs, chemical relaxers, and excessive tensions from braids ...

Indian stock market on July 15 will track key corporate developments. HCLTech cut its FY26 margin guidance after weak Q1. Tata Technologies, Rallis India, and Tejas Networks reported mixed results.

While hair loss is typically associated with men, the condition is also prevalent among women. Losing your hair can be incredibly disheartening, with many sufferers reporting a lack of confidence, but ...

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...